iCanQuit Smoking Cessation Among Hispanic Adults

Part of paid clinical trials in Seattle, Washington.

Sponsor
Fred Hutchinson Cancer Center
Study ID
NCT06811038
Phase
PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cigarette Smoking-Related Carcinoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • iCanQuit Smartphone App Smoking Cessation Program — DEVICE
    Receive access to iCanQuit app, with daily push notifications
  • Nicotine Gum — DRUG
    Receive nicotine replacement therapy gum
  • Nicotine Patch — DRUG
    Receive nicotine replacement therapy patch(es)
  • Nicotine Lozenge — DRUG
    Receive nicotine replacement therapy lozenge(s)
  • Survey Administration — OTHER
    Ancillary studies
  • Interview — OTHER
    Ancillary studies

Study Details

This phase III trial compares a smartphone application with or without nicotine replacement therapy in improving smoking cessation among Hispanic adults who would like to quit smoking. The iCanQuit smartphone application focuses on skills for managing urges, motivation, and relapse prevention with personalized quit plans. Nicotine replacement therapy works by giving small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking without any of the other harmful chemicals found in tobacco products.

Key Dates

Start date
Aug 15, 2026
Status verified
Jun 2026
Primary completion
Jul 1, 2029
Completion
Jul 1, 2030

Study Design

Enrollment
854 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Arm I (iCanQuit application)
    Participants receive access to the iCanQuit smartphone application for 12 months and complete personalized quit plans with education regarding managing urges, motivation, and relapse prevention, on-demand help with tracking of daily cigarette consumption, and monitoring of urges passed without smoking.
  • Experimental: Arm II (iCanQuit application and NRT)
    Participants receive access to the iCanQuit smartphone application for 12 months and complete personalized quit plans with education regarding managing urges, motivation, and relapse prevention, on-demand help with tracking of daily cigarette consumption, and monitoring of urges passed without smoking. Participants also receive NRT patch(es) and gum to use per the usage instructions tailored to the participants' baseline smoking levels. In addition, participants receive daily push notifications with NRT dosage and refill reminders for 12 months.

Primary Outcome Measure

30-day point prevalence abstinence (PPA) [ Time Frame: At 12 months post randomization ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Fred Hutch/University of Washington Cancer ConsortiumSeattleWashington98109
Jonathan Bricker, PhD
[email protected]
206-667-5074
Jonathan Bricker, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Seattle, WA

By research site
Fred Hutch/University of Washington Cancer Consortium· Seattle, WA

Related Studies